Fulgent Genetics Inc. (FLGT)
NASDAQ · Healthcare
Fulgent Genetics Inc. Operating Income 2014–2025
Fulgent Genetics Inc. annual/quarterly operating income history and growth rate from 2014 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Fulgent Genetics Inc. operating income for the quarter ending March 31, 2026 was -34.6 M, a 74.90% increase year-over-year.
- Fulgent Genetics Inc. operating income for the twelve months ending March 31, 2026 was -89.5 M, a 55.43% increase year-over-year.
- Fulgent Genetics Inc. annual operating income for 2025 was -91.1 M, a 23.24% increase from 2024.
- Fulgent Genetics Inc. annual operating income for 2024 was -73.9 M, a 62.20% decrease from 2023.
- Fulgent Genetics Inc. annual operating income for 2023 was -195.5 M, a 209.52% decrease from 2022.
- Fulgent Genetics Inc. annual operating income for 2022 was 178.5 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Fulgent Genetics Inc. Operating Income — FAQ
Fulgent Genetics Inc. (FLGT) operating income over the last 12 years — annual and quarterly figures with year-over-year growth and charts.
What is Fulgent Genetics Inc.'s operating income?
Fulgent Genetics Inc. (FLGT) reported operating income of -$91M for fiscal 2025.
Where can I see FLGT's operating income history?
The chart and table above show Fulgent Genetics Inc.'s operating income by year and by quarter, including the growth rate.